Momenta Pharmaceuticals Announces Executive Promotions. PR Newswire | April 12, 2005 | COPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information) Copyright

CAMBRIDGE, Mass., April 12 /PRNewswire-FirstCall/ -- Momenta Pharmaceuticals, Inc. , a biotechnology company developing drugs based on its proprietary sugar sequencing technology, announced senior management promotions. Ganesh Venkataraman, Ph.D., has been promoted to Senior Vice President, Research, and Steven B. Brugger has been promoted to Senior Vice President, Strategic Business Operations.

"The promotions of Ganesh and Steve are a reflection of the significant leadership that each has brought to Momenta as we have made rapid progress over the past several ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Study data from University of Florida provide new insights into biotechnology. Newspaper article from: Biotech Week ; ...which can be traced back to the Cell Theory of Matthias Jakob Schleiden and Theodor Schwann, and the discovery of genetic...of plant biotechnology: from the Cell Theory of Schleiden and Schwann to biotech crops. Plant Cell Reports...

For more facts and information, see all results

Find more facts and information related to the article "Momenta Pharmaceuticals Announces Executive ..."